Intervention

Brachytherapy

ClinicalTrials.gov intervention label

Clinical trials24
Recruiting2
Common conditions23
Lead sponsors shown15

Clinical trials

24 shown
Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate CancerNCT07182279 · 2025-08-01
RECRUITING
High Dose Rate (HDR) Brachytherapy Salvage After ProstatectomyNCT06982469 · 2020-05-05
RECRUITING
Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate CancerNCT06129851 · 2023-11-20
NOT_YET_RECRUITING
Prostate Reirradiation Toxicity Outcomes Feasibility StudyNCT05614700 · 2022-11-15
NOT_YET_RECRUITING
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate CancerNCT05100472 · 2021-10-19
ACTIVE_NOT_RECRUITING
Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate CancerNCT05224869 · 2021-08-31
TERMINATED
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)NCT04634877 · 2021-01-10
ACTIVE_NOT_RECRUITING
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)NCT04221945 · 2020-05-12
COMPLETED
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation TherapyNCT03543189 · 2018-10-03
COMPLETED
Deformable Registration of Multi-parametric MRI to Intra-operative Transrectal Ultrasound for Prostate BrachytherapyNCT02790216 · 2016-06-01
UNKNOWN
Salvage Brachytherapy and Interstitial Hyperthermia for Locally Recurrent Prostate Carcinoma Following Radiation TherapyNCT03238066 · 2015-04-01
UNKNOWN
Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and UltrasoundNCT02225925 · 2014-10-01
COMPLETED
Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate CancerNCT01982786 · 2014-04-22
COMPLETED
Modulated Electro-Hyperthermia Plus Chemo-radiation for Locally Advanced Cervical Cancer Patients in South AfricaNCT03332069 · 2014-01-09
UNKNOWN
Focal Therapy for Prostate CancerNCT01802307 · 2013-02-01
WITHDRAWN
Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or BrachytherapyNCT01777802 · 2013-01-02
COMPLETED
High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate CancerNCT01655836 · 2012-10-04
ACTIVE_NOT_RECRUITING
Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate CancerNCT01374087 · 2011-11-01
TERMINATED
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerNCT01368588 · 2011-07-01
ACTIVE_NOT_RECRUITING
Implant Radiation Therapy or Surgery in Treating Patients With Prostate CancerNCT01098331 · 2008-06-01
TERMINATED
Brachytherapy Radiation Directly to the Liver in Breast Cancer Patients With Metastatic to LiverNCT00891800 · 2007-07-01
TERMINATED
Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate CancerNCT00770822 · 2007-04-01
UNKNOWN
Brachytherapy for Prostatic Carcinoma PatientsNCT00525720 · 2006-08-01
ACTIVE_NOT_RECRUITING
Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate CancerNCT00039624 · 2002-06-03
COMPLETED

Common conditions

Prostate Cancer18Adenocarcinoma of the Prostate2Brachytherapy1Breast Cancer1Breast Cancer Metastatic to the Liver1Cervical Cancer1Endometrial Neoplasms1Local Recurrence of Malignant Tumor of Prostate1Lung Cancer1Melanoma1Prostate Cancer (Adenocarcinoma)1Prostate Disease1Prostatectomy1Prostatic Neoplasms1Radiotherapy Side Effect1Radiotherapy; Complications1Recurrent Prostate Cancer1Stage IIA Prostate Cancer1Stage IIB Prostate Cancer1Stage IIC Prostate Cancer AJCC v81Stage III Prostate Cancer AJCC v81Stage IV Prostate Cancer AJCC v81Uterine Cervical Neoplasms1

Leading sponsors

Merck Sharp & Dohme LLC2Canadian Cancer Trials Group1Clinica Universidad de Navarra, Universidad de Navarra1H. Lee Moffitt Cancer Center and Research Institute1Icahn School of Medicine at Mount Sinai1Ipsen1Jeffrey Kotzen1M.D. Anderson Cancer Center1Mayo Clinic1Memorial Sloan Kettering Cancer Center1National Cancer Institute (NCI)1Radiation Therapy Oncology Group1Sheba Medical Center1Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University1

Trial status mix

COMPLETED6
ACTIVE_NOT_RECRUITING5
TERMINATED4
UNKNOWN4
NOT_YET_RECRUITING2
RECRUITING2
WITHDRAWN1

Phase mix

PHASE29
NA7
PHASE34
PHASE13

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.